Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression

Schizophr Res. 2010 May;118(1-3):292-9. doi: 10.1016/j.schres.2009.12.027. Epub 2010 Jan 13.

Abstract

Although the etiology of schizophrenia remains unknown, diverse neuropathological evidence suggests a disorder of synaptic connectivity. Apoptosis is a form of cell death that helps determine synaptic circuitry during neurodevelopment and altered regulation of apoptosis has been implicated in schizophrenia. Prostate apoptosis response-4 (Par-4) is an upstream regulator of apoptosis preferentially localized to synapses. Brain Par-4 levels are upregulated in response to pro-apoptotic stimuli in rodent models and in patients with classic neurodegenerative diseases. Recently, Par-4 was also found to form a complex with the dopamine D2 receptor (D2DR) in competition with the calcium-binding protein calmodulin, implicating Par-4 as an important regulatory component in normal dopamine signaling. Interestingly, mutant mice with disrupted Par-4/D2DR interaction demonstrated depressive-like behaviors, suggesting a potential role for Par-4 in both depression and schizophrenia. In this study, Par-4, D2DR and calmodulin protein levels were measured using semiquantitative Western blotting in postmortem temporal cortex in subjects with schizophrenia, major depression and bipolar disorder. Compared to normal controls, mean Par-4 levels appeared slightly lower in schizophrenia and bipolar disorder. However, in major depression, Par-4 was decreased by 67% compared to normal controls. No differences were found between any groups for calmodulin or for the D2DR 48 kDa band. The D2DR 98 kDa band was lower by 50% in the schizophrenia compared to control groups. Changes in the Par-4/D2DR signaling pathway represent a novel mechanism that may link apoptotic and dopamine signaling pathways in major depression and schizophrenia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Apoptosis Regulatory Proteins / metabolism*
  • Bipolar Disorder / drug therapy
  • Bipolar Disorder / pathology*
  • Calmodulin / metabolism
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / pathology*
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation / drug effects
  • Humans
  • Male
  • Middle Aged
  • Postmortem Changes
  • Rats
  • Rats, Mutant Strains
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 / metabolism*
  • Schizophrenia / drug therapy
  • Schizophrenia / pathology*
  • Synaptophysin / metabolism
  • Temporal Lobe / drug effects
  • Temporal Lobe / metabolism*

Substances

  • Antidepressive Agents
  • Apoptosis Regulatory Proteins
  • Calmodulin
  • Receptors, Dopamine D2
  • Synaptophysin
  • prostate apoptosis response-4 protein